- Home
- WPC vs BMRN Comparison
WPC vs BMRN Comparison
Compare WPC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPC
- BMRN
- Stock Information
- Founded
- WPC 1973
- BMRN 1996
- Country
- WPC United States
- BMRN United States
- Employees
- WPC N/A
- BMRN N/A
- Industry
- WPC Real Estate Investment Trusts
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WPC Real Estate
- BMRN Health Care
- Exchange
- WPC Nasdaq
- BMRN Nasdaq
- Market Cap
- WPC 13.7B
- BMRN 12.1B
- IPO Year
- WPC 1998
- BMRN 1999
- Fundamental
- Price
- WPC $62.92
- BMRN $58.00
- Analyst Decision
- WPC Hold
- BMRN Buy
- Analyst Count
- WPC 13
- BMRN 22
- Target Price
- WPC $93.08
- BMRN $93.43
- AVG Volume (30 Days)
- WPC 1.3M
- BMRN 2.1M
- Earning Date
- WPC 07-29-2025
- BMRN 08-04-2025
- Dividend Yield
- WPC 5.67%
- BMRN N/A
- EPS Growth
- WPC N/A
- BMRN 152.82
- EPS
- WPC 1.94
- BMRN 2.71
- Revenue
- WPC $1,595,990,000.00
- BMRN $2,950,227,000.00
- Revenue This Year
- WPC $4.73
- BMRN $12.23
- Revenue Next Year
- WPC $5.88
- BMRN $9.99
- P/E Ratio
- WPC $32.38
- BMRN $21.48
- Revenue Growth
- WPC N/A
- BMRN 19.36
- 52 Week Low
- WPC $52.91
- BMRN $52.93
- 52 Week High
- WPC $66.10
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- WPC 50.35
- BMRN 59.75
- Support Level
- WPC $61.61
- BMRN $56.76
- Resistance Level
- WPC $63.08
- BMRN $59.98
- Average True Range (ATR)
- WPC 1.04
- BMRN 1.44
- MACD
- WPC -0.15
- BMRN 0.62
- Stochastic Oscillator
- WPC 45.25
- BMRN 81.47
About WPC W. P. Carey Inc. REIT
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.